These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19273156)

  • 1. Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy.
    Zhao P; Sharma AC; Ren J
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1708-15. PubMed ID: 19273156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
    Mobini R; Maschke H; Waagstein F
    Autoimmun Rev; 2004 Jun; 3(4):277-84. PubMed ID: 15246023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?
    Fu M
    Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B; Padberg K; Schultheiss HP; Strauer BE
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial injury due to G-protein coupled receptor-autoimmunity.
    Matsui S; Fu ML
    Jpn Heart J; 1998 May; 39(3):261-74. PubMed ID: 9711178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of autoimmunity in myocarditis.
    Rose NR
    Ernst Schering Res Found Workshop; 2006; (55):141-54. PubMed ID: 16331858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.
    Nussinovitch U; Shoenfeld Y
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):298-308. PubMed ID: 21207192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune mechanisms underlying dilated cardiomyopathy.
    Yoshikawa T; Baba A; Nagatomo Y
    Circ J; 2009 Apr; 73(4):602-7. PubMed ID: 19246813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-specific cardiac autoantibodies in dilated cardiomyopathy. Frequency and clinical correlates in Polish patients.
    Bilińska ZT; Caforio AL; Grzybowski J; Michalak E; Kuśmierczyk-Droszcz B; Goldman JH; Haven AJ; Rydlewska-Sadowska W; McKenna WJ; Ruzyłło W
    Eur Heart J; 1995 Dec; 16(12):1907-11. PubMed ID: 8682025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.
    Mascaro-Blanco A; Alvarez K; Yu X; Lindenfeld J; Olansky L; Lyons T; Duvall D; Heuser JS; Gosmanova A; Rubenstein CJ; Cooper LT; Kem DC; Cunningham MW
    Autoimmunity; 2008 Sep; 41(6):442-53. PubMed ID: 18781470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.
    Taneja V; David CS
    J Autoimmun; 2009; 33(3-4):260-9. PubMed ID: 19811893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
    Caforio AL; Mahon NJ; Tona F; McKenna WJ
    Eur J Heart Fail; 2002 Aug; 4(4):411-7. PubMed ID: 12167378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M; Wallukat G; Englert A; Hetzer R
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
    Caforio AL; Mahon NJ; Mckenna WJ
    Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of anti-cardiac immunity in dilated cardiomyopathy.
    Caforio AL; Mahon NG; McKenna WJ
    Ernst Schering Res Found Workshop; 2006; (55):169-93. PubMed ID: 16329663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
    Castellano G; Affuso F; Di Conza P; Fazio S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.